Efficacy and Safety of GLP-1 Receptor Agonists and SGLT-2 Inhibitors in the Treatment of Diabetes Mellitus and Obesity in Liver Transplant Recipients: A Systematic Review. This evidence concerns the gene SLC5A2 and obesity due to melanocortin 4 receptor deficiency.